Differential Effect of Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Diabetes Management
A subanalysis of the JPAD trial
Article Information
vol. 34 no. 6 1277-1283
PubMed
Published By
Print ISSN
Online ISSN
History
- Received December 29, 2010
- Accepted March 21, 2011
- Published in print June 1, 2011.
- Published online May 26, 2011.
- Published first April 22, 2011.
Article Versions
- Previous version (April 22, 2011 - 13:10).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2011 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.
Author Information
- Sadanori Okada, MD1,
- Takeshi Morimoto, MD, PHD2,
- Hisao Ogawa, MD, PHD3,
- Masao Kanauchi, MD, PHD1,
- Masafumi Nakayama, MD, PHD3,
- Shiro Uemura, MD, PHD1,
- Naofumi Doi, MD, PHD1,
- Hideaki Jinnouchi, MD, PHD4,
- Masako Waki, MD, PHD5,
- Hirofumi Soejima, MD, PHD3,
- Mio Sakuma, MD, PHD2,
- Yoshihiko Saito, MD, PHD1,6⇓ and
- for the Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial Investigators
- 1First Department of Internal Medicine, Nara Medical University, Shijo-cho, Kashihara, Nara, Japan
- 2Center for Medical Education, Kyoto University Graduate School of Medicine, Konoe-cho, Yoshida, Sakyo-ku, Kyoto, Japan
- 3Department of Cardiovascular Medicine, Graduate School of Medical Science, Kumamoto University Honjo, Kumamoto, Japan
- 4Jinnouchi Hospital, Kyuhhonnji, Kumamoto, Japan
- 5Department of Internal Medicine, Division of Endocrinology and Metabolism, Shizuoka City Hospital, Ote-cho, Aoi-ku, Shizuoka, Japan
- 6Department of Regulatory Medicine of Blood Pressure, Nara Medical University, Shijo-cho, Kashihara, Nara, Japan
- Corresponding author: Yoshihiko Saito, yssaito{at}naramed-u.ac.jp.